Friday, June 26, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 847 of 1,261

  1. US 8563503

    Antibiotic, its nucleotide sequence, methods of construction and uses thereof

    PROTEIN DESIGN LAB, LTD. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  2. US 8563515

    Tight junction protein modulators and uses thereof

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  3. US 8563569

    Compositions and methods for inhibition of the JAK pathway

    Rigel Pharmaceuticals, Inc. · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  4. US 8563575

    Fused heterocyclic compounds

    Takeda Pharmaceutical Company Limited · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  5. US 8563573

    Azaindole derivatives as CFTR modulators

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  6. US 8563576

    Tri-cyclic pyrazolopyridine kinase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  7. US 8563593

    Formulations of (R)-1-(2,2-difluorobenzo[D] [1,3] dioxol-5-yl)-N-(1-(2,3-dihydroxypropyl)-6-fluoro-2-(1-hydroxy-2-methylpropan-2-yl)-1H-indol-5-yl)cyclopropanecarboxamide

    Vertex Pharmaceuticals Incorporated · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  8. US 8563022

    Particles for cell targeting

    The Board of Regents of the University of Texas System · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  9. US 8563014

    Modafinil oral lyophilizate

    Teva Sante · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  10. US 8563001

    Multicomponent immunogenic composition for the prevention of beta-hemolytic streptococcal (BHS) disease

    Regents of the University of Minnesota · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  11. US 8562955

    Light-activated tooth whitening method

    DISCUS DENTAL, LLC · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  12. US 8562949

    Radiolabeled dihydrotetrabenazine derivatives and their use as imaging agents

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  13. US 8562948

    Somatostatin analogs with inhibitory activity to growth hormone release

    The Regents of the University of California · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  14. US 8562589

    Swallowable drug delivery device and method of delivery

    Rani Therapeutics, LLC · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  15. US 8562965

    Polymer derivatives comprising an acetal or ketal branching point

    Nektar Therapeutics · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  16. US 8563035

    Oral tablet compositions of dexlansoprazole

    Sanovel Ilac Sanayi Ve Ticaret Anomin Sirketi · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  17. US 8563034

    Dual release oral tablet compositions of dexlansoprazole

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  18. US 8563023

    Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens

    Covidien LP · Granted Oct 22, 2013 · Expires Oct 17, 2033

    granted

  19. DE 102012007671

    Pellets mit hohem Wirkstoffgehalt

    ACINO PHARMA AG [CH] · Granted Oct 17, 2013 · Expires Oct 12, 2033

    granted

  20. US 8557806

    Methods of treating or preventing autoimmune diseases with 2,4-pyrimidinediamine compounds

    Rigel Pharmaceuticals, Inc. · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  21. US 8557245

    Methods for treating bone cancer by administering a nerve growth factor antagonist antibody

    Regents of the University of Minnesota · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  22. US 8557290

    Multifunction nanoconjugates for imaging applications and targeted treatment

    Northwestern University · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  23. US 8557764

    Methods of modulating immune function

    The Regents of the University of Colorado, a Body Corporate · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

  24. US 8557800

    Sphingosine kinase inhibitors

    Apogee Biotechnology Corporation · Granted Oct 15, 2013 · Expires Oct 10, 2033

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.